Dapagliflozin Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs used in diabetes | Endocrine System
Items (12m)
819
Total Quantity
16.8K
NHS Cost
£20.9K
vs National Avg
-34.6%
MAPLE ACCESS PARTNERSHIP LLP prescribed 819 items of Dapagliflozin over the last 12 months at a cost of £20,862 to the NHS. This is 34.6% below the national average prescribing rate. Dapagliflozin is classified under Drugs used in diabetes in the BNF.
Monthly Prescribing Trend
Jun 2026
54
Jun 2026
52
Jun 2026
64
Jun 2026
69
Jun 2026
66
Jun 2026
77
Jun 2026
66
Jun 2026
75
Jun 2026
72
Jun 2026
77
Jun 2026
77
Jun 2026
70
Prescribing Details
| Total Items | 819 |
|---|---|
| Total Quantity | 16,772 |
| Total NHS Cost | £20,862 |
| Presentations | 2 different forms |
| vs National Average | -34.6% |
Dapagliflozin Prescribing Comparison
| This practice | 819 items |
|---|---|
| National average per practice | 1,252 items |
| Difference | -34.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.